10 years of historical data (2016–2025) · Healthcare · Medical - Instruments & Supplies
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Avantor, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 11.6x P/FCF, 46% below the 5-year average of 21.6x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $5.8B | $7.8B | $14.4B | $15.5B | $14.3B | $25.3B | $16.4B | $7.3B | — | — | — |
| Enterprise Value | $9.3B | $11.4B | $18.2B | $20.8B | $20.2B | $32.0B | $21.0B | $12.2B | — | — | — |
| P/E Ratio → | -10.81 | — | 20.26 | 48.57 | 20.88 | 49.58 | 312.78 | — | — | — | — |
| P/S Ratio | 0.88 | 1.19 | 2.12 | 2.22 | 1.91 | 3.42 | 2.57 | 1.21 | — | — | — |
| P/B Ratio | 1.03 | 1.40 | 2.41 | 2.95 | 2.95 | 6.02 | 6.14 | 2.96 | — | — | — |
| P/FCF | 11.63 | 15.73 | 20.76 | 21.40 | 20.18 | 29.99 | 18.92 | 24.08 | — | — | — |
| P/OCF | 9.23 | 12.48 | 17.09 | 17.80 | 16.98 | 26.50 | 17.66 | 20.57 | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Avantor, Inc.'s enterprise value stands at 56.9x EBITDA, 107% above its 5-year average of 27.4x. The Healthcare sector median is 14.1x, placing the stock at a 303% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.73 | 2.68 | 2.98 | 2.69 | 4.33 | 3.29 | 2.02 | — | — | — |
| EV / EBITDA | 56.93 | 69.30 | 12.19 | 18.90 | 13.18 | 23.67 | 19.08 | 12.84 | — | — | — |
| EV / EBIT | — | — | 16.93 | 29.86 | 18.12 | 32.96 | 56.85 | 25.41 | — | — | — |
| EV / FCF | — | 22.96 | 26.24 | 28.69 | 28.50 | 37.97 | 24.22 | 40.38 | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Avantor, Inc. earns an operating margin of -3.8%. Operating margins have compressed from 10.0% to -3.8% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -9.2% indicates the company is currently destroying shareholder equity.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 32.7% | 32.7% | 33.6% | 33.9% | 34.6% | 33.9% | 32.5% | 31.8% | 31.0% | 34.7% | 46.2% |
| Operating Margin | -3.8% | -3.8% | 16.0% | 10.0% | 15.0% | 13.2% | 11.1% | 9.1% | 7.1% | -16.9% | 1.4% |
| Net Profit Margin | -8.1% | -8.1% | 10.5% | 4.6% | 9.1% | 7.8% | 1.8% | 0.6% | -1.5% | -9.0% | -6.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -9.2% | -9.2% | 12.7% | 6.4% | 15.2% | 16.7% | 4.5% | 1.5% | — | — | — |
| ROA | -4.4% | -4.4% | 5.7% | 2.4% | 5.0% | 4.8% | 1.2% | 0.4% | -0.9% | -1.9% | -3.7% |
| ROIC | -2.0% | -2.0% | 8.0% | 4.9% | 7.8% | 8.0% | 7.2% | 7.5% | 7.8% | -6.3% | 1.0% |
| ROCE | -2.4% | -2.4% | 10.0% | 6.0% | 9.3% | 9.2% | 8.1% | 6.3% | 4.6% | -4.1% | 1.0% |
Solvency and debt-coverage ratios — lower is generally safer
Avantor, Inc. carries a Debt/EBITDA ratio of 24.1x, which is highly leveraged (640% above the sector average of 3.3x). Net debt stands at $3.6B ($3.9B total debt minus $365M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.71 | 0.71 | 0.68 | 1.05 | 1.29 | 1.67 | 1.83 | 2.08 | — | — | — |
| Debt / EBITDA | 24.06 | 24.06 | 2.72 | 5.04 | 4.09 | 5.20 | 4.44 | 5.38 | 8.46 | — | 18.46 |
| Net Debt / Equity | — | 0.64 | 0.64 | 1.00 | 1.22 | 1.60 | 1.72 | 2.00 | — | — | — |
| Net Debt / EBITDA | 21.83 | 21.83 | 2.55 | 4.80 | 3.85 | 4.97 | 4.18 | 5.19 | 8.24 | — | 17.57 |
| Debt / FCF | — | 7.23 | 5.48 | 7.29 | 8.33 | 7.98 | 5.31 | 16.30 | 41.40 | — | 28.68 |
| Interest Coverage | -1.60 | -1.60 | 4.90 | 2.44 | 4.20 | 4.46 | 1.20 | 1.09 | 0.78 | -1.29 | 0.12 |
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.78x means Avantor, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The quick ratio of 1.18x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has improved from 1.61x to 1.78x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.78 | 1.78 | 1.07 | 1.61 | 1.60 | 1.71 | 1.80 | 1.88 | 1.73 | 1.66 | 2.15 |
| Quick Ratio | 1.18 | 1.18 | 0.70 | 1.05 | 1.05 | 1.11 | 1.20 | 1.22 | 1.12 | 1.03 | 1.25 |
| Cash Ratio | 0.26 | 0.26 | 0.13 | 0.18 | 0.22 | 0.21 | 0.23 | 0.17 | 0.17 | 0.17 | 0.46 |
| Asset Turnover | — | 0.56 | 0.56 | 0.54 | 0.56 | 0.53 | 0.65 | 0.62 | 0.59 | 0.12 | 0.61 |
| Inventory Turnover | 5.39 | 5.39 | 6.16 | 5.56 | 5.37 | 5.60 | 5.83 | 5.79 | 6.03 | 1.17 | 3.04 |
| Days Sales Outstanding | — | 59.86 | 55.66 | 60.26 | 59.20 | 60.39 | 63.56 | 59.75 | 57.96 | 256.03 | 46.41 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Avantor, Inc. returns 1.4% to shareholders annually primarily through share buybacks.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | 0.2% | 0.3% | 0.4% | 0.4% | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | 82.8% | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 4.9% | 2.1% | 4.8% | 2.0% | 0.3% | — | — | — | — |
| FCF Yield | 8.6% | 6.4% | 4.8% | 4.7% | 5.0% | 3.3% | 5.3% | 4.2% | — | — | — |
| Buyback Yield | 1.4% | 1.0% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 36.1% | — | — | — |
| Total Shareholder Yield | 1.4% | 1.0% | 0.1% | 0.1% | 0.3% | 0.4% | 0.5% | 36.6% | — | — | — |
| Shares Outstanding | — | $679M | $682M | $678M | $679M | $600M | $583M | $401M | $497M | $497M | $491M |
Compare AVTR with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $6B | -10.8 | 56.9 | 11.6 | 32.7% | -3.8% | -9.2% | -2.0% | 24.1 | |
| $176B | 26.7 | 19.0 | 27.9 | 37.7% | 18.2% | 13.1% | 7.5% | 3.8 | |
| $124B | 34.7 | 18.1 | 23.5 | 60.9% | 20.9% | 7.1% | 5.9% | 2.4 | |
| $585M | -294.3 | 18.1 | 13.8 | 62.6% | 6.8% | -1.3% | 3.7% | 4.4 | |
| $5B | 36.3 | 16.4 | 21.9 | 34.8% | 5.1% | 9.3% | 7.3% | 2.6 | |
| $23B | 32.5 | 21.5 | 42.2 | 57.8% | 28.2% | 29.3% | 20.3% | 1.3 | |
| $33B | 25.8 | 19.7 | 28.9 | 52.4% | 21.3% | 20.6% | 13.5% | 1.9 | |
| $7B | 103.1 | 36.3 | 28.9 | 64.8% | 8.4% | 3.7% | 3.4% | 2.1 | |
| $46B | 44.3 | 32.1 | 43.8 | 61.8% | 31.6% | 66.2% | 42.5% | 0.7 | |
| $9B | -62.5 | 13.0 | 17.3 | 30.5% | 12.6% | -4.3% | 6.3% | 3.4 | |
| $80B | 31.5 | 21.4 | 30.1 | 48.9% | 16.1% | 59.4% | 16.5% | 3.3 | |
| Healthcare Median | — | 22.1 | 14.1 | 18.7 | 63.9% | -5.3% | -33.7% | -10.8% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 10 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Thermo Fisher Scientific Inc..
Start ComparisonQuick answers to the most common questions about buying AVTR stock.
Avantor, Inc.'s current P/E ratio is -10.8x. The historical average is 34.8x.
Avantor, Inc.'s current EV/EBITDA is 56.9x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 24.2x.
Avantor, Inc.'s return on equity (ROE) is -9.2%. The historical average is 6.8%.
Based on historical data, Avantor, Inc. is trading at a P/E of -10.8x. Compare with industry peers and growth rates for a complete picture.
Avantor, Inc. has 32.7% gross margin and -3.8% operating margin.
Avantor, Inc.'s Debt/EBITDA ratio is 24.1x, indicating high leverage. A ratio above 4x may signal elevated financial risk.